Skip to main content

Table 4 Distribution of discordant results by LBC results

From: A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off

LBC

HR HC2-ve, CER+ve (N/%)

CER-ve, HR HC2+ve (N/%)

Total (N)

Normal (Pap I/II)

75/84.3%

14/15.7%

89

ASC-US (Pap IIw)

7/58.3%

5/41.7%

12

ASC-H, AGUS (Pap III)

1/100.0%

0

1

LSIL, HSIL (Pap IIID)

6/20.7%

23/79.3%

29

HSIL, CIS (Pap IVa)

0

2/100.0%

2

Total

89

44

133

  1. +ve: positive; −ve: negative.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us